These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29176351)

  • 1. Bacteremia in Patients With Liver Cirrhosis: Prevalence and Predictors of Multidrug Resistant Organisms.
    Addo Smith JN; Yau R; Russo HP; Putney K; Restrepo A; Garey KW; Sofjan AK
    J Clin Gastroenterol; 2018 Aug; 52(7):648-654. PubMed ID: 29176351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of multidrug-resistant bacteremia in liver cirrhosis.
    Kim A; Song BG; Kang W; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Goh MJ
    Korean J Intern Med; 2024 May; 39(3):448-457. PubMed ID: 38715233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
    Fernández J; Prado V; Trebicka J; Amoros A; Gustot T; Wiest R; Deulofeu C; Garcia E; Acevedo J; Fuhrmann V; Durand F; Sánchez C; Papp M; Caraceni P; Vargas V; Bañares R; Piano S; Janicko M; Albillos A; Alessandria C; Soriano G; Welzel TM; Laleman W; Gerbes A; De Gottardi A; Merli M; Coenraad M; Saliba F; Pavesi M; Jalan R; Ginès P; Angeli P; Arroyo V;
    J Hepatol; 2019 Mar; 70(3):398-411. PubMed ID: 30391380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.
    Fernández J; Acevedo J; Castro M; Garcia O; de Lope CR; Roca D; Pavesi M; Sola E; Moreira L; Silva A; Seva-Pereira T; Corradi F; Mensa J; Ginès P; Arroyo V
    Hepatology; 2012 May; 55(5):1551-61. PubMed ID: 22183941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
    Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
    World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study.
    Mascitti H; Duran C; Nemo EM; Bouchand F; Câlin R; Descatha A; Gaillard JL; Lawrence C; Davido B; Barbier F; Dinh A
    Antimicrob Resist Infect Control; 2018; 7():116. PubMed ID: 30288256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteremia in patients with liver cirrhosis in the era of increasing antimicrobial resistance: single-center epidemiology.
    Milovanovic T; Pantic I; Velickovic J; Oluic B; Vlaisavljevic Z; Dragasevic S; Stojkovic Lalosevic M; Dumic I
    J Infect Dev Ctries; 2021 Dec; 15(12):1883-1890. PubMed ID: 35044947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical distribution of multidrug-resistant bacteria (3537 isolates) in a tertiary Chinese hospital (January 2012-December 2013).
    Jia XQ; Pang F; Chen JZ; Jiang LX
    Pathol Biol (Paris); 2015 Feb; 63(1):21-3. PubMed ID: 25553645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with cirrhosis and SBP: Increase in multidrug-resistant organisms and complications.
    Li H; Wieser A; Zhang J; Liss I; Markwardt D; Hornung R; Neumann-Cip AC; Mayerle J; Gerbes A; Steib CJ
    Eur J Clin Invest; 2020 Feb; 50(2):e13198. PubMed ID: 31886517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center.
    Tandon P; Delisle A; Topal JE; Garcia-Tsao G
    Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1291-8. PubMed ID: 22902776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients.
    Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; Roca J; Cruzado JM; Carratalà J
    Transplantation; 2013 Nov; 96(9):843-9. PubMed ID: 23883973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Prevalence of Multidrug-Resistant Bacteria in Libyan War Casualties Admitted to a Tertiary Care Hospital, Germany.
    Lohr B; Pfeifer Y; Heudorf U; Rangger C; Norris DE; Hunfeld KP
    Microb Drug Resist; 2018 Jun; 24(5):578-584. PubMed ID: 29039717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of bacteremia and antimicrobial resistance, and associated factors among patients transferred from long-term care hospital.
    Kim S; Jo S; Lee JB; Jin Y; Jeong T; Yoon J; Kim SE; Park B; Bhally H
    Am J Emerg Med; 2019 Aug; 37(8):1516-1526. PubMed ID: 30466804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections.
    Labricciosa FM; Sartelli M; Abbo LM; Barbadoro P; Ansaloni L; Coccolini F; Catena F
    Surg Infect (Larchmt); 2018 Apr; 19(3):264-272. PubMed ID: 29298133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA.
    Sofjan AK; Musgrove RJ; Beyda ND; Russo HP; Lasco TM; Yau R; Restrepo A; Garey KW
    J Glob Antimicrob Resist; 2018 Dec; 15():41-47. PubMed ID: 29842975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit].
    Huang X; Li G; Yi L; Li M; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):667-71. PubMed ID: 26255016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
    Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
    Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of multidrug resistance on outcomes in hematologic cancer patients with bacterial bloodstream infections.
    Park KH; Jung YJ; Lee HJ; Kim HJ; Maeng CH; Baek SK; Han JJ; Jeon W; Kim DY; Lee YM; Lee MS
    Sci Rep; 2024 Jul; 14(1):15622. PubMed ID: 38972913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.